Sphenopalatine ganglion stimulation with acupuncture for perennial allergic rhinitis:a multicentre randomized traditional Chinese acupuncture techniques (verum acupuncture) controlled trial

Chinese Academy of Chinese Medical Sciences (China)0 个研究点目标入组 96 人开始时间: 2014年3月27日最近更新: 2020年9月14日

试验速览

•1. Diagnosis of moderate-severe or severe PER, according to the criteria of allergic rhinitis and its impact on asthma (ARIA) initiative
•2. Have had PER for greater than 4 days/week, and greater than 4 consecutive weeks, and disease course is more than 1 year
•3. Age range is from 18 to 60 years, either sex
•4. Completed AR baseline questionnaire and provided written informed consent
•5. The physical sign score is greater than or equal to 1 and the symptom score is greater than or equal to 4

•1. Acute sinusitis, active asthma, or diagnosed or suspicious pneumonia
•2. Nasal abnormalities or rhinopolypus (polypoid lesion can be included)
•3. Had applied antihistamines, anticholinergics, corticosteroids, decongestants or antibiotics within 2 weeks before enrollment
•4. Received systemically administered corticosteroids within 6 months before enrolment or special immune therapy within 1 year
•5. Received alternative and complementary modality, i.e. acupuncture or herbal medication for treating AR within 2 months
•6. Pregnant woman or someone is planning for pregnancy
•7. Suffering serious medical conditions such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidaemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment
•8. Heavy smoker

发起方

Chinese Academy of Chinese Medical Sciences (China)